المؤلفون: N. V. Zhukov

المصدر: Онкогематология, Vol 0, Iss 2, Pp 40-46 (2022)

مصطلحات موضوعية: gastric adenocarcinoma, metastatic cancer, blood transfusion, intravascular hemolysis, microangiopathic hemolytic anemia, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://oncohematology.abvpress.ru/ongm/article/view/643; https://doaj.org/toc/1818-8346; https://doaj.org/toc/2413-4023

URL الوصول: https://doaj.org/article/164925ea71d24c758933b1dca9a5f6dc

المؤلفون: V. V. Ptushkin, N. V. Zhukov, S. V. Minenko, A. Y. Popov, D. M. Mheidze, L. Y. Andreeva

المصدر: Онкогематология, Vol 0, Iss 1-2, Pp 86-96 (2022)

مصطلحات موضوعية: non-hodgkin's lymphomas, high-dose chemotherapy, hemopoietic stem cell transplantation, rituximab, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://oncohematology.abvpress.ru/ongm/article/view/653; https://doaj.org/toc/1818-8346; https://doaj.org/toc/2413-4023

URL الوصول: https://doaj.org/article/6f125326694147cb94304187ce37dd65

المؤلفون: N. V. Zhukov

المصدر: Онкогематология, Vol 0, Iss 3, Pp 69-76 (2022)

مصطلحات موضوعية: anemia, erythropoiesis-stimulating drugs, darbepoetin α, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://oncohematology.abvpress.ru/ongm/article/view/729; https://doaj.org/toc/1818-8346; https://doaj.org/toc/2413-4023

URL الوصول: https://doaj.org/article/6c44e8dc7c044a0b8406de8ff7ebca3f

المؤلفون: S. V. Minenko, A. Yu. Popov, N. V. Zhukov, O. M. Votyakova, V. V. Ptushkin

المصدر: Онкогематология, Vol 0, Iss 4, Pp 11-16 (2022)

مصطلحات موضوعية: multiple myeloma, high-dose chemotherapy, autologous peripheral blood stem cell transplantation, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://oncohematology.abvpress.ru/ongm/article/view/746; https://doaj.org/toc/1818-8346; https://doaj.org/toc/2413-4023

URL الوصول: https://doaj.org/article/c64ef0ba59af417a864c050ffaaa530e

المؤلفون: N. V. Zhukov

المصدر: Онкогематология, Vol 0, Iss 4 (2022)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://oncohematology.abvpress.ru/ongm/article/view/692; https://doaj.org/toc/1818-8346; https://doaj.org/toc/2413-4023

URL الوصول: https://doaj.org/article/f3eb1b4b199845a893e2c2ada2b34ad8

المؤلفون: N. V. Zhukov

المصدر: Онкогематология, Vol 0, Iss 4, Pp 59-60 (2022)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://oncohematology.abvpress.ru/ongm/article/view/773; https://doaj.org/toc/1818-8346; https://doaj.org/toc/2413-4023

URL الوصول: https://doaj.org/article/a9f781712b2743088df39f29e1c099ac

المؤلفون: N. V. Zhukov

المصدر: Онкогематология, Vol 11, Iss 2, Pp 52-59 (2016)

مصطلحات موضوعية: clinical studies, oncology, hematology, clinical trial phase, statistical significance, statistical power, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://oncohematology.abvpress.ru/ongm/article/view/198; https://doaj.org/toc/1818-8346; https://doaj.org/toc/2413-4023

URL الوصول: https://doaj.org/article/e78828ba24414114a3e8f43dfd24dcef

المؤلفون: V. V. Ptushkin, N. V. Zhukov, V. I. Borisov, S. V. Minenko, Yu. V. Larina

المصدر: Онкогематология, Vol 10, Iss 2, Pp 37-45 (2015)

مصطلحات موضوعية: chemotherapy, dose intensity, toxicity, neutropenia, granulocyte colony stimulating factor, pegfilgrastim, lipegfilgrastim, Lonkvex, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://oncohematology.abvpress.ru/index.php/ongm/article/view/143; https://doaj.org/toc/1818-8346

URL الوصول: https://doaj.org/article/e6309fd445814f1f87d68647a6043428

المؤلفون: G. A. Melnichenko, I. S. Stilidi, . ., B. Ya. Alexeev, D. G. Beltsevich, A. O. Raykhman, N. S. Kuznetsov, N. V. Zhukov, V. Yu. Bokhyan

المصدر: Медицинский вестник Юга России, Vol 0, Iss 1, Pp 4-20 (2015)

مصطلحات موضوعية: adrenal tumors, adrenal cortical cancer, pheochromocytoma, paraganglioma, hypercortysolism, mitotane, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.medicalherald.ru/jour/article/view/184; https://doaj.org/toc/2219-8075; https://doaj.org/toc/2618-7876

URL الوصول: https://doaj.org/article/baca0efbdca14969bd24eae4e0bc4123

المؤلفون: N. V. Zhukov, S. A. Rumyantsev, S. A. Lukyanov

المصدر: Онкогематология, Vol 9, Iss 4, Pp 54-66 (2015)

مصطلحات موضوعية: malignant tumors, cancer therapy, clinical trials, treatment standards, pharmacoeconomics, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://oncohematology.abvpress.ru/index.php/ongm/article/view/132; https://doaj.org/toc/1818-8346

URL الوصول: https://doaj.org/article/abf1ca2b01a3439ead492600f1c496e4

المؤلفون: N. V. Zhukov, A. R. Zaretskiy, S. A. Lukyanov, S. A. Rumyantsev

المصدر: Онкогематология, Vol 9, Iss 4, Pp 28-36 (2015)

مصطلحات موضوعية: circulating tumor DNA, liquid biopsy, sequencing, methylation, malignant tumors, intratumoral heterogeneity, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://oncohematology.abvpress.ru/index.php/ongm/article/view/129; https://doaj.org/toc/1818-8346

URL الوصول: https://doaj.org/article/7bfd43c8aef149ff903637c42d6f75be

المؤلفون: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasiev, N. B. Mikhaylova, V. B. Larionova, Ye. A. Demina, N. G. Tyurina, M. A. Vernyuk, Ye. Ye. Karamanesht, A. G. Rumyantsev

المصدر: Онкогематология, Vol 9, Iss 3, Pp 32-40 (2015)

مصطلحات موضوعية: Hodgkin , s lymphoma, relapse, primary-resistant disease, high-dose chemotherapy, autologous transplantation, the mobilization of hematopoietic progenitor cells, survival, mortality, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://oncohematology.abvpress.ru/index.php/ongm/article/view/121; https://doaj.org/toc/1818-8346

URL الوصول: https://doaj.org/article/9e6e7f17fa354ebf9f9c5a8190d253ae

المؤلفون: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasiev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, N. G. Tyurina, M. A. Vernyuk, E. E. Karamanesht, A. G. Rumyantsev

المصدر: Онкогематология, Vol 9, Iss 2, Pp 37-44 (2014)

مصطلحات موضوعية: Hodgkin's lymphoma, relapse, primary refractory disease, high-dose chemotherapy, autologous transplantation, mobilization of hematopoietic progenitor cells, survival, mortality, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://oncohematology.abvpress.ru/index.php/ongm/article/view/113; https://doaj.org/toc/1818-8346

URL الوصول: https://doaj.org/article/a6a5819cace74f079c937d2e1c275049

المؤلفون: M. A. Vernyuk, N. G. Tyurina, O. A. Pavlova, A. M. Chervontseva, N. V. Zhukov

المصدر: Онкогематология, Vol 8, Iss 4, Pp 18-23 (2014)

مصطلحات موضوعية: primary mediastinal B-large cell lymphoma, MACOP-B, rituximab, autologous stem cell transplantation, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://oncohematology.abvpress.ru/index.php/ongm/article/view/14; https://doaj.org/toc/1818-8346

URL الوصول: https://doaj.org/article/92ced134509c4f979192382fbc36a309

المؤلفون: N. V. Zhukov, A. G. Rumyantsev

المصدر: Онкогематология, Vol 8, Iss 3, Pp 6-15 (2014)

مصطلحات موضوعية: oncology, chemotherapy, radiotherapy, surgery, target therapy, clinical trials, history, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://oncohematology.abvpress.ru/index.php/ongm/article/view/20; https://doaj.org/toc/1818-8346

URL الوصول: https://doaj.org/article/eca2515fa36c46608ffdce98aa1dc077

المؤلفون: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasyev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, E. E. Karamanesht, N. G. Tyurina, O. A. Pavlova, A. G. Rumyantsev, A. D. Kaprin

المصدر: Онкогематология, Vol 8, Iss 3, Pp 35-41 (2014)

مصطلحات موضوعية: Hodgkin lymphoma, high-dose chemotherapy, hematopoietic stem cell transplantation, toxicity, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://oncohematology.abvpress.ru/index.php/ongm/article/view/24; https://doaj.org/toc/1818-8346

URL الوصول: https://doaj.org/article/f6115523b8514ec88678b6e2d7768b68

المؤلفون: E. T. Bairamov, A. V. Belonogov, V. V. Brusnichkina, A. V. Bulakh, M. Y. Byahov, S. N. Gurov, G. G. Eremeev, N. V. Zhukov, L. G. Zhukova, L. M. Kogonia, P. V. Koposov, L. K. Ovchinnikova, V. V. Radlevich, E. A. Samyshina, A. P. Seryakov, M. D. Ter-Ovanesov, I. E. Shumskaya

المصدر: Issledovaniâ i Praktika v Medicine, Vol 2, Iss 2, Pp 102-104 (2015)

مصطلحات موضوعية: Medicine

وصف الملف: electronic resource

Relation: https://www.rpmj.ru/rpmj/article/view/71; https://doaj.org/toc/2410-1893

URL الوصول: https://doaj.org/article/6ab2f01cc6f84ffcaa6050ad4c720d71

المؤلفون: G. B. Sagoyan, N. V. Zhukov, V. V. Strelnikov, R. A. Khagurov, A. M. Suleymanova, Yu. M. Mareeva, R. V. Garbuzov, E. N. Imyanitov, Yu. V. Dinikina, S. I. Kutsev, E. K. Donyush, K. I. Kirgizov, N. A. Semenova, Yu. A. Polyaev, I. S. Kletskaya, A. A. Maschan, S. R. Varfolomeeva, Г. Б. Сагоян, Н. В. Жуков, В. В. Стрельников, Р. А. Хагуров, А. М. Сулейманова, Ю. М. Мареева, Р. В. Гарбузов, Е. Н. Имянитов, Ю. В. Диникина, С. И. Куцев, Е. К. Донюш, К. И. Киргизов, Н. А. Семенова, Ю. А. Поляев, И. С. Клецкая, А. А. Масчан, С. Р. Варфоломеева

المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 10, № 2 (2023); 117-130 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 10, № 2 (2023); 117-130 ; 2413-5496 ; 2311-1267

مصطلحات موضوعية: сиролимус, PIK3CA mutation, overgrowth spectrum, CLOVES, CLAPO, Klippel–Trenaunay syndrome, macrodactyly, lipomatosis, vascular malformations, epidermal nevus, alpelisib, sirolimus, мутация PIK3CA, спектр синдромов избыточного роста, синдром Клиппеля– Треноне, макродактилия, липоматоз, сосудистые мальформации, эпидермальный невус, алпелисиб

وصف الملف: application/pdf

Relation: https://journal.nodgo.org/jour/article/view/944/831; https://journal.nodgo.org/jour/article/view/944/832; Сагоян Г.Б., Клецкая И.С., Имянитов Е.Н., Мареева Ю.М., Жуков Н.В., Хагуров Р.А., Сулейманова А.М. Спектр синдромов избыточного роста, связанных с мутацией PIK3CA. Обзор литературы. Российскийжурнал детской гематологии и онкологии. 2022;9(1):29–44. doi:10.21682/2311-1267-2022-9-1-29-44.; Canaud G., Hammill A.M., Adams D., Vikkula M., Keppler-Noreuil K.M. A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations. Orphanet J Rare Dis. 2021;16(1):306. doi:10.1186/s13023-021-01929-8.; Nunnery S.E., Mayer I.A. Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer Drugs. 2020;80:1685–97. doi:10.1007/s40265-020-01394-w.; Madsen R.R., Vanhaesebroeck B., Semple R.K. Cancer-Associated PIK3CA Mutations in Overgrowth Disorders. Trends Mol Med. 2018;24(10):856–70. doi:10.1016/j.molmed.2018.08.003.; Douzgou S., Rawson M., Baselga E., Danielpour M., Faivre L., Kashanian A., Keppler-Noreuil K.M., Kuentz P., Mancini G.M.S., Maniere M.C., Martinez-Glez V., Parker V.E., Semple R.K., Srivastava S., Vabres P., De Wit M.Y., Graham J.M. Jr, Clayton-Smith J., Mirzaa G.M., Biesecker L.G. A standard of care for individuals with PIK3CA-related disorders: An international expert consensus statement. Clin Genet. 2022;101(1):32–47. doi:10.1111/cge.14027.; Mirzaa G., Graham J.M. Jr, Keppler-Noreuil K.M. PIK3CA-Related Overgrowth Spectrum. In: Adam M.P., Everman D.B., Mirzaa G.M., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023.; Keppler-Noreuil K.M., Rios J.J., Parker V.E., Semple R.K., Lindhurst M.J., Sapp J.C., Alomari A., Ezaki M., Dobyns W., Biesecker L.G. PIK3CArelated overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, diff erential diagnosis, and evaluation. Am J Med Genet A. 2015;167A(2):287–95. doi:10.1002/ajmg.a.36836.; Canaud G., López Gutiérrez J.C., Irvine A., Ankrah N., Ridolfi A., Adams D.M. LBA23 EPIK-P1: Retrospective chart review study of patients (pts) with PIK3CA-related Overgrowth Spectrum (PROS) who have received alpelisib (ALP) as part of a compassionate use programme. Dev Ther. 2021;32(Suppl 5):S1297. doi:10.1016/j.annonc.2021.08.2097.; Garreta Fontelles G., Pardo Pastor J., Grande Moreillo C. Alpelisib to treat CLOVES syndrome, a member of the PIK3CA-related overgrowth syndrome spectrum. Br J Clin Pharmacol. 2022;88(8):3891–5. doi:10.1111/bcp.15270.; Morin G., Degrugillier-Chopinet C., Vincent M., Fraissenon A., Aubert H., Chapelle C., Hoguin C., Dubos F., Catteau B., Petit F., Mezel A., Domanski O., Herbreteau G., Alesandrini M., Boddaert N., Boutry N., Broissand C., Kevin Han T., Branle F., Sarnacki S., Blanc1 T., Guibaud L., Canaud G. Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib. J Exp Med. 2022;219(3):e20212148. doi:10.1084/jem.20212148.; Madsen R.R., Semple R.K. PIK3CA-related overgrowth: silver bullets from the cancer arsenal? Trends Mol Med. 2022;28(4):255–7. doi:10.1016/j.molmed.2022.02.009.; Parker V.E.R., Keppler-Noreuil K.M., Faivre L., Luu M., Oden N.L., De Silva L., Sapp J.C., Andrews K., Bardou M., Chen K.Y., Darling T.N., Gautier E., Goldspiel B.R., Hadj-Rabia S., Harris J., Kounidas G., Kumar P., Lindhurst M.J., Loff roy R., Martin L., Phan A., Rother K.I., Widemann B.C., Wolters P.L., Coubes C., Pinson L., Willems M., Vincent-Delorme C.; PROMISE Working Group; Vabres P., Semple R.K., Biesecker L.G. Safety and efficacy of low-dose sirolimus in the PIK3CArelated overgrowth spectrum. Genet Med. 2019;21(5):1189–98. doi:10.1038/s41436-018-0297-9.; https://journal.nodgo.org/jour/article/view/944

الاتاحة: https://journal.nodgo.org/jour/article/view/944
https://doi.org/10.21682/2311-1267-2023-10-2-117-123

المؤلفون: L. L. Rabaeva, N. V. Zhukov, Л. Л. Рабаева, Н. В. Жуков

المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 9, № 2 (2022); 46-53 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 9, № 2 (2022); 46-53 ; 2413-5496 ; 2311-1267

مصطلحات موضوعية: дети и подростки, antiemetic therapy, antiemetics, scales and questionnaires for assessments of nausea and vomiting, children and adolescents, индуцированные цитостатической терапией, противорвотная терапия, антиэметики, шкалы и опросники для оценки тошноты и рвоты

وصف الملف: application/pdf

Relation: https://journal.nodgo.org/jour/article/view/829/734; Жуков Н.В., Казакова Л.Л., Новичкова Г.А. Профилактика и лечение тошноты и рвоты у детей и подростков, получающих противоопухолевую терапию. Текущее состояние и потенциальные пути улучшения. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2020;19(4):205–23. doi:10.24287/1726-1708-2020-19-4-205-223.; Coates A., Abraham S., Kaye S.B., Sowerbutts T., Frewin C., Fox R.M., Tattersall M.H. On the receiving end-patient perception of the side-eff ects of cancer chemotherapy. Eur J Cancer Clin Oncol. 1983;19(2):203–8. doi:10.1016/0277-5379(83)90418-2.; Griffi n A.M., Butow P.N., Coates A.S., Childs A.M., Ellis P.M., Dunn S.M., Tattersall M.H. On the receiving end. V: Patient perceptions of the side eff ects of cancer chemotherapy in 1993. Ann Oncol. 1996;7(2):189–95. doi:10.1093/oxfordjournals.annonc.a010548.; de Boer-Dennert M., de Wit R., Schmitz P.I., Djontono J., Beurden V., Stoter G., Verweij J. Patient perceptions of the side-eff ects of chemotherapy: the infl uence of 5HT3 antagonists. Br J Cancer. 1997;76(8):1055–61. doi:10.1038/bjc.1997.507.; Köseoglu V., Kürekçi A.E., Sarici U., Atay A.A., Ozcan O. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. Eur J Pediatr. 1998;157(10):806–10. doi:10.1007/s004310050940.; Dick G.S., Meller S.T., Pinkerton C.R. Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. Arch Dis Child. 1995;73(3):243–5. doi:10.1136/adc.73.3.243.; Alvarez O., Freeman A., Bedros A., Call S.K., Volsch J., Kalbermatter O., Halverson J., Convy L., Cook L., Mick K. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapyinduced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol. 1995;17(2):145–50. doi:10.1097/00043426-199505000-00008.; Zeltzer L.K., LeBaron S., Zeltzer P.M. A prospective assessment of chemotherapy-related nausea and vomiting in children with cancer. Am J Pediatr Hematol Oncol. 1984;6(1):5–16. PMID: 6711763.; Zeltzer L., LeBaron S., Zeltzer P.M. The eff ectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy. J Clin Oncol. 1984;2(6):683–90. doi:10.1200/JCO.1984.2.6.683.; Phipps S., Dunavant M., Jayawardene D., Srivastiva D.K. Assessment of health-related quality of life in acute in-patient settings: use of the BASES instrument in children undergoing bone marrow transplantation. Int J Cancer Suppl. 1999;12:18–24. doi:10.1002/(sici)1097-0215(1999)83:12+3.0.co;2-l.; Freyer D.R., Lin L., Mack J.W., Maurer S.H., McFatrich M., Baker J.N., Jacobs S.S., Lucas N., Withycombe J.S., Tomlinson D., Villabroza K.R., Waldron M.K., Hinds P.S., Reeve B.B. Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials. J Clin Oncol. 2022;40(15):1623–34. doi:10.1200/JCO.21.02669.; Baxter A.L., Watcha M.F., Baxter W.V., Leong T., Wyatt M.M. Development and validation of a pictorial nausea rating scale for children. Pediatrics. 2011;127(6):e1542–9. doi:10.1542/peds.2010-1410.; Dupuis L.L., Taddio A., Kerr E.N., Kelly A., MacKeigan L. Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents. Pharmacotherapy. 2006;26(9):1221–31. doi:10.1592/phco.26.9.1221.; Paw Cho Sing E., Robinson P.D., Flank J., Holdsworth M., Thackray J., Freedman J., Gibson P., Orsey A.D., Patel P., Phillips R., Portwine C., Raybin J.L., Cabral S., Sung L., Dupuis L.L. Classifi cation of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline. Pediatr Blood Cancer. 2019;66(5):e27646. doi:10.1002/pbc.27646.; Patel P., Robinson P.D., Thackray J., Flank J., Holdsworth M.T., Gibson P., Orsey A., Portwine C., Freedman J., Madden J.R., Phillips R., Sung L., Dupuis L.L. Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update. Pediatr Blood Cancer. 2017;64(10). doi:10.1002/pbc.26542.; Dupuis L.L., Robinson P.D., Boodhan S., Holdsworth M., Portwine C., Gibson P., Phillips R., Maan C., Stefi n N., Sung L.; Pediatric Oncology Group of Ontario. Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients. Pediatr Blood Cancer. 2014;61(8):1506–12. doi:10.1002/pbc.25063.; Flank J., Robinson P.D., Holdsworth M., Phillips R., Portwine C., Gibson P., Maan C., Stefi n N., Sung L., Dupuis L.L. Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer. Pediatr Blood Cancer. 2016;63(7):1144–51. doi:10.1002/pbc.25955.; POGO Emetogenicity Classifi cation Guideline Final-rev-250111.2019 Aug 11. Available from: https://www.pogo.ca/_media/File/guidelines/POGO%20Emetogenicity%20Classification%20Guideline%20Finalrev-%20250111.pdf.; Bakhshi S., Batra A., Biswas B., Dhawan D., Paul R., Sreenivas V. Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebocontrolled trial. Support Care Cancer. 2015;23(11):3229–37. doi:10.1007/s00520-015-2714-9.; Kang H.J., Loftus S., Taylor A., DiCristina C., Green S., Zwaan C.M. Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial. Lancet Oncol. 2015;16(4):385–94. doi:10.1016/S1470-2045(15)70061-6.; Dupuis L.L., Nathan P.C. Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines. Paediatr Drugs. 2010;12(1):51–61. doi:10.2165/11316190-000000000-00000.; Carroll C., Clinton F., Smith A., Fox A., Capra M., Pears J., Owens C. Revised antiemetics guidelines and the impact on nutritional status during induction chemotherapy in children with high-risk neuroblastoma. Pediatr Blood Cancer. 2018;65(12):e27386. doi:10.1002/pbc.27386.; Flank J., Nadeem K., Moledina S., Khanna M., Schindera C., Punnett A., Dupuis L.L. Nausea and vomiting in children and adolescents receiving intrathecal methotrexate: A prospective, observational study. Pediatr Blood Cancer. 2017;64(10). doi:10.1002/pbc.26603.; Flank J., Schechter T., Gibson P., Johnston D.L., Orsey A.D., Portwine C., Sung L., Dupuis L.L. Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study. Support Care Cancer. 2018;26(2):549–55. doi:10.1007/s00520-017-3864-8.; Flank J., Sparavalo J., Vol H., Hagen L., Stuhler R., Chong D., Courtney S., Doyle J.J., Gassas A., Schechter T., Dupuis L.L. The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: a prospective study. Bone Marrow Transplant. 2017;52(9):1294–9. doi:10.1038/bmt.2017.112.; Kovacevic A., Sivananthan A., Patel R., Patel P., Vennettilli A., Paw Cho Sing E., Zupanec S., Alexander S., Sung L., Dupuis L.L. Chemotherapy-induced nausea and vomiting from oral chemotherapy for childhood acute lymphoblastic leukaemia: feasibility study. BMJ Support Palliat Care. 2019;bmjspcare-2019-002022. doi:10.1136/bmjspcare-2019-002022.; Molassiotis A., Coventry P.A., Stricker C.T., Clements C., Eaby B., Velders L., Rittenberg C., Gralla R.J. Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. J Pain Symptom Manage. 2007;34(2):148–59. doi:10.1016/j.jpainsymman.2006.10.018.; Warr J.K., Chambers C.R., Cusano F.L., Cuthbert C.A., Mah M.S. Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre. J Oncol Pharm Pract. 2015;21(5):348–57. doi:10.1177/1078155214540317.; https://journal.nodgo.org/jour/article/view/829

الاتاحة: https://journal.nodgo.org/jour/article/view/829
https://doi.org/10.21682/2311-1267-2022-9-2-46-53

المؤلفون: P. V. Kralichkin, M. V. Teleshova, I. V. Sidorov, D. M. Konovalov, A. E. Druy, N. N. Merkulov, D. G. Akhaladze, A. P. Troitskaya, I. E. Volkova, T. V. Shamanskaya, N. V. Zhukov, N. V. Myakova, D. Y. Kachanov

المصدر: Pediatric Hematology/Oncology and Immunopathology. 21:142-151

مصطلحات موضوعية: Oncology, Immunology, Pediatrics, Perinatology and Child Health, Immunology and Allergy, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ab7270356f2c14d5e778015ca55c3b32
https://doi.org/10.24287/1726-1708-2022-21-4-142-151